[
  {
    "ts": "2026-02-25T01:15:25+00:00",
    "headline": "Why Eli Lilly Stock Slumped Today",
    "summary": "Investors worried that the company could take quite a revenue hit due to a competitor's move.",
    "url": "https://www.fool.com/investing/2026/02/24/why-eli-lilly-stock-slumped-today/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "2e66560f-1dd1-3a2b-9f89-0b2c31ce3255",
      "content": {
        "id": "2e66560f-1dd1-3a2b-9f89-0b2c31ce3255",
        "contentType": "STORY",
        "title": "Why Eli Lilly Stock Slumped Today",
        "description": "",
        "summary": "Investors worried that the company could take quite a revenue hit due to a competitor's move.",
        "pubDate": "2026-02-25T01:15:25Z",
        "displayTime": "2026-02-25T01:15:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/0d11ab642e40bc0f6c99b7e07085c2ef",
          "originalWidth": 1400,
          "originalHeight": 683,
          "caption": "Person in lab gear looking through a microscope.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/etNdo1t.8L5zLK_gCH9c9Q--~B/aD02ODM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/0d11ab642e40bc0f6c99b7e07085c2ef.cf.webp",
              "width": 1400,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6VUVujFcQVXRmg3n5b7EtQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/0d11ab642e40bc0f6c99b7e07085c2ef.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/24/why-eli-lilly-stock-slumped-today/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-eli-lilly-stock-slumped-011525647.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-25T13:01:03+00:00",
    "headline": "Novo Nordisk's Loss Is Eli Lilly's Gain",
    "summary": "Eli Lilly and Company (NYSE:LLY) shares are up on Monday as the company benefits from positive market sentiment following Novo Nordisk A/S’ (NYSE:NVO) disappointing trial results for a weight-loss drug, adding pressure as broader markets edged lower. Eli Lilly Gains as Novo Nordisk Trial Setback Novo Nordisk’s stock hit a 52-week low after its REDEFINE 4 trial failed to demonstrate non-inferiority in weight loss compared to Eli Lilly’s tirzepatide, marketed under the Zepbound and Mounjaro brands",
    "url": "https://finance.yahoo.com/news/novo-nordisks-loss-eli-lillys-130103846.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "598577b8-c4ae-3908-af01-7676cb7d0216",
      "content": {
        "id": "598577b8-c4ae-3908-af01-7676cb7d0216",
        "contentType": "STORY",
        "title": "Novo Nordisk's Loss Is Eli Lilly's Gain",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE:LLY) shares are up on Monday as the company benefits from positive market sentiment following Novo Nordisk A/S’ (NYSE:NVO) disappointing trial results for a weight-loss drug, adding pressure as broader markets edged lower. Eli Lilly Gains as Novo Nordisk Trial Setback Novo Nordisk’s stock hit a 52-week low after its REDEFINE 4 trial failed to demonstrate non-inferiority in weight loss compared to Eli Lilly’s tirzepatide, marketed under the Zepbound and Mounjaro brands",
        "pubDate": "2026-02-25T13:01:03Z",
        "displayTime": "2026-02-25T13:01:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Benzinga/abbaaecb0fde99ee3964b9d76b965665",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IUU._bBhgVBKB51v8QU4QQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/abbaaecb0fde99ee3964b9d76b965665.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u28Izd0a40lCOZ5kJER0Ig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/abbaaecb0fde99ee3964b9d76b965665.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "http://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisks-loss-eli-lillys-130103846.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisks-loss-eli-lillys-130103846.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-25T12:57:47+00:00",
    "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
    "summary": "Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a “Meltdown Monday.” Stocks rallied on Tuesday, and all major indices closed higher. While not recouping all of the losses from Monday, a strong bounce-back was a welcome sight for investors. A combination of a rebound in technology ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
    "url": "https://247wallst.com/investing/2026/02/25/here-are-wednesdays-top-wall-street-analyst-research-calls-abbvie-angel-studios-first-solar-ibm-kroger-molson-coors-oracle-workday-and-more/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "4169d733-42be-3151-835b-ba5bd346912c",
      "content": {
        "id": "4169d733-42be-3151-835b-ba5bd346912c",
        "contentType": "STORY",
        "title": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
        "description": "",
        "summary": "Pre-Market Stock Futures: Futures are trading higher this morning, but what a difference a day makes after a “Meltdown Monday.” Stocks rallied on Tuesday, and all major indices closed higher. While not recouping all of the losses from Monday, a strong bounce-back was a welcome sight for investors. A combination of a rebound in technology ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: AbbVie, Angel Studios, First Solar, IBM, Kroger, Molson Coors, Oracle, Workday, and More",
        "pubDate": "2026-02-25T12:57:47Z",
        "displayTime": "2026-02-25T12:57:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8oHqLvL4LSIh_k84TF28VQ--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M2B5MfoEY0V7wX_NrqStUQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/8338f370f249766d037be2988fc68cf3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/02/25/here-are-wednesdays-top-wall-street-analyst-research-calls-abbvie-angel-studios-first-solar-ibm-kroger-molson-coors-oracle-workday-and-more/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wednesday-top-wall-street-analyst-125747007.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "TREX"
            },
            {
              "symbol": "KNSL"
            },
            {
              "symbol": "ENPH"
            },
            {
              "symbol": "OVV"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "LYV"
            },
            {
              "symbol": "PFG"
            },
            {
              "symbol": "ANGX"
            },
            {
              "symbol": "FSLR"
            },
            {
              "symbol": "IBM"
            },
            {
              "symbol": "KR"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "WDAY"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-25T12:08:55+00:00",
    "headline": "Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low",
    "summary": "After finding itself some unwanted attention this week, Novo Nordisk (NYSE:NVO) has dropped 22% in the past week and 56% over the past year, now sitting near its 52-week low. As a result, Reddit sentiment has followed along with this downward shift, sliding from a quarterly average of 56 to a weekly average of 43 ... Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low",
    "url": "https://247wallst.com/investing/2026/02/25/novo-nordisk-cuts-wegovy-prices-in-half-while-its-stock-sits-near-a-52-week-low/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "dd10fce5-8ccc-35c8-be63-f4fbe3726787",
      "content": {
        "id": "dd10fce5-8ccc-35c8-be63-f4fbe3726787",
        "contentType": "STORY",
        "title": "Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low",
        "description": "",
        "summary": "After finding itself some unwanted attention this week, Novo Nordisk (NYSE:NVO) has dropped 22% in the past week and 56% over the past year, now sitting near its 52-week low. As a result, Reddit sentiment has followed along with this downward shift, sliding from a quarterly average of 56 to a weekly average of 43 ... Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low",
        "pubDate": "2026-02-25T12:08:55Z",
        "displayTime": "2026-02-25T12:08:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/a0d3a0e2f4155ed8d8da3ce27eac142a",
          "originalWidth": 686,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rq76f8F0oZe4klQDn0Hnfw--~B/aD01MTI7dz02ODY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/a0d3a0e2f4155ed8d8da3ce27eac142a.cf.webp",
              "width": 686,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ALAZXFUT9E0wT0UGpJHY3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/a0d3a0e2f4155ed8d8da3ce27eac142a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/02/25/novo-nordisk-cuts-wegovy-prices-in-half-while-its-stock-sits-near-a-52-week-low/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-cuts-wegovy-prices-120855525.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]